223 related articles for article (PubMed ID: 20093276)
1. In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.
Mouton-Barbosa E; Roux-Dalvai F; Bouyssié D; Berger F; Schmidt E; Righetti PG; Guerrier L; Boschetti E; Burlet-Schiltz O; Monsarrat B; Gonzalez de Peredo A
Mol Cell Proteomics; 2010 May; 9(5):1006-21. PubMed ID: 20093276
[TBL] [Abstract][Full Text] [Related]
2. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
3. CSF biomarker discovery using label-free nano-LC-MS based proteomic profiling: technical aspects.
Huang JT; McKenna T; Hughes C; Leweke FM; Schwarz E; Bahn S
J Sep Sci; 2007 Feb; 30(2):214-25. PubMed ID: 17390615
[TBL] [Abstract][Full Text] [Related]
4. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
[TBL] [Abstract][Full Text] [Related]
5. Mass Spectrometry-Based Assay for Targeting Fifty-Two Proteins of Brain Origin in Cerebrospinal Fluid.
Batruch I; Lim B; Soosaipillai A; Brinc D; Fiala C; Diamandis EP
J Proteome Res; 2020 Aug; 19(8):3060-3071. PubMed ID: 32315192
[TBL] [Abstract][Full Text] [Related]
6. Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.
Perrin RJ; Payton JE; Malone JP; Gilmore P; Davis AE; Xiong C; Fagan AM; Townsend RR; Holtzman DM
PLoS One; 2013; 8(5):e64314. PubMed ID: 23700471
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
8. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
[TBL] [Abstract][Full Text] [Related]
9. Affinity depletion versus relative protein enrichment: a side-by-side comparison of two major strategies for increasing human cerebrospinal fluid proteome coverage.
Jankovska E; Svitek M; Holada K; Petrak J
Clin Proteomics; 2019; 16():9. PubMed ID: 30890900
[TBL] [Abstract][Full Text] [Related]
10. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
11. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
12. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Sensitivity and Reproducibility of Targeted Proteomic Analysis Using Data-Independent Acquisition for Serum and Cerebrospinal Fluid Proteins.
Cho KC; Oh S; Wang Y; Rosenthal LS; Na CH; Zhang H
J Proteome Res; 2021 Sep; 20(9):4284-4291. PubMed ID: 34384221
[TBL] [Abstract][Full Text] [Related]
14. Expanding the cerebrospinal fluid endopeptidome.
Hansson KT; Skillbäck T; Pernevik E; Kern S; Portelius E; Höglund K; Brinkmalm G; Holmén-Larsson J; Blennow K; Zetterberg H; Gobom J
Proteomics; 2017 Mar; 17(5):. PubMed ID: 28044435
[TBL] [Abstract][Full Text] [Related]
15. Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags.
Dayon L; Hainard A; Licker V; Turck N; Kuhn K; Hochstrasser DF; Burkhard PR; Sanchez JC
Anal Chem; 2008 Apr; 80(8):2921-31. PubMed ID: 18312001
[TBL] [Abstract][Full Text] [Related]
16. Sample Fractionation Techniques for CSF Peptide Spectral Library Generation.
Pacharra S; Marcus K; May C
Methods Mol Biol; 2019; 2044():69-77. PubMed ID: 31432407
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of the cerebrospinal fluid peptidome and proteome.
Zougman A; Pilch B; Podtelejnikov A; Kiehntopf M; Schnabel C; Kumar C; Mann M
J Proteome Res; 2008 Jan; 7(1):386-99. PubMed ID: 18052119
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Evaluation of Different Protein Fractions of Cerebrospinal Fluid Using
Birke R; Krause E; Schümann M; Blasig IE; Haseloff RF
Methods Mol Biol; 2019; 2044():119-128. PubMed ID: 31432410
[TBL] [Abstract][Full Text] [Related]
19. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
Oh JH; Pan S; Zhang J; Gao J
Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
[TBL] [Abstract][Full Text] [Related]
20. Identification of human cerebrospinal fluid proteins and their distribution in an in vitro microdialysis sampling system.
Wetterhall M; Bergquist J; Hillered L; Hjort K; Dahlin AP
Eur J Pharm Sci; 2014 Jun; 57():34-40. PubMed ID: 24361471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]